Dalfampridine
Who holds supplier records for Dalfampridine? 10 organisations hold a current record for Dalfampridine: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6), Italy (2) and Germany (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Dalfampridine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/dalfampridine
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Dalfampridine. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Alkem Laboratories LimitedIndia Company GMP cert on recordActive DMF 27637 · latest filing Nov 2013
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 27843 · latest filing Jan 2014
- CU CHEMIE UETIKON GMBHGermany Company GMP cert on recordActive DMF 17860 · latest filing Nov 2004
- INDUSTRIALE CHIMICA SRLItaly Company GMP cert on recordActive DMF 27623 · latest filing Oct 2013
- Intas Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 27819 · latest filing Dec 2013
- JUBILANT PHARMOVA LTDIndiaActive DMF 24718 · latest filing Mar 2011
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 33146 · latest filing Sept 2018
- PROCOS SPAItaly Company GMP cert on recordActive DMF 27647 · latest filing Oct 2013
- Shandong New Time Pharmaceutical Co LtdCompany GMP cert on recordActive DMF 42075 · latest filing Jul 2025
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 27662 · latest filing Nov 2013
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (1)
Organisations whose Type II DMFs for Dalfampridine are no longer active. These show a past filing, not current supply.
Show all 1 historical record
- India · Inactive DMF 25695 · filed May 2012
Overview
Dalfampridine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL284348).
Chemical identity
- IUPAC name
- pyridin-4-amine
- Canonical SMILES
- C1=CN=CC=C1N
- InChIKey
- NUKYPUAOHBNCPY-UHFFFAOYSA-N
- Synonyms
- Ampyra, Ampyra extended release, Dalfampridine, EL-970, Fampridina, Fampridine, Fampridine (4-aminopyridine), Fampridine accord, Fampyra, NSC-15041, 4-aminopyridine, pyridin-4-amine
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Potassium Channel Blocker
- Mechanism of action
- Potassium Channel Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Dalfampridine?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Dalfampridine: Alkem Laboratories Limited (India), APITORIA PHARMA PRIVATE LTD (India), CU CHEMIE UETIKON GMBH (Germany), INDUSTRIALE CHIMICA SRL (Italy), Intas Pharmaceuticals Ltd. (India), JUBILANT PHARMOVA LTD (India), MICRO LABS LTD (India) and PROCOS SPA (Italy), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Dalfampridine Drug Master Files are active?
Alkem Laboratories Limited (DMF 27637), APITORIA PHARMA PRIVATE LTD (DMF 27843), CU CHEMIE UETIKON GMBH (DMF 17860), INDUSTRIALE CHIMICA SRL (DMF 27623), Intas Pharmaceuticals Ltd. (DMF 27819), JUBILANT PHARMOVA LTD (DMF 24718), MICRO LABS LTD (DMF 33146) and PROCOS SPA (DMF 27647) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Dalfampridine records mean?
1 organisation has only inactive Type II DMFs for Dalfampridine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Dalfampridine supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Dalfampridine?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.